1 AGM -attending expensive for shareholder -in the dead of winter- health issues of travel --Why not virtual ?
2 Has Medmira been collecting data for fda since Mar 2021 on covid + ? Are final discussions continuing ?
3 Will this excruciatingly long wait end happily for the small short and long term(eg 10 yr+) shareholder ?
4 Is FDA to blame for this excruciatingly long wait ?
5 Is this stupid wait MEDMIRA'S FAULT ?
6 Has Medmira developed an incomplete OMICRON test ?
7 Is Medmira's omicron test more difficult than first presented ?
8 Has the mystery company needed for sample collection already proven itself and its procedure ???
9 Why does MEDMIRA need a PARTNER in the U.S. ? Is Webb DX no longer a partner ?
10 Will FDA approval happen this year -2022?
11 Will CE approval happen this year -2022? What does early 2022 mean in medmira time?
12 How long will worker subsidization last ?
13 Do you think your iR department acts in the best interests of all shareholders ?
14 MEDMIRA is always starting but never finishing ---- WHY ???
15 Shares sell lower and lower-sellers hitting the bid much too often -will this trend go away?
16 Are there as many new jobs at Medmira as there are "INDEED" job ads for Medmira positions ? just repeats or replacements ?